pI: 9.9617 |
Length (AA): 532 |
MW (Da): 59331 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 3 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
42 | 393 | 3mkq (A) | 16 | 373 | 20.00 | 0.000014 | 1 | 0.797854 | 0.64 |
126 | 166 | 5cxb (B) | 448 | 488 | 32.00 | 0.58 | 0.55 | 0.435268 | 0.07 |
130 | 205 | 5fa5 (B) | 124 | 196 | 32.00 | 0.011 | 0.51 | 0.515057 | -0.51 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Ortholog group members (OG5_128309)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT2G47990 | transducin family nucleolar protein with WD40 repeats |
Babesia bovis | BBOV_IV004010 | WD domain, G-beta repeat containing protein |
Brugia malayi | Bm1_14340 | Src-associated protein SAW |
Candida albicans | CaO19.11092 | similar to S. cerevisiae YMR093W |
Candida albicans | CaO19.3609 | similar to S. cerevisiae YMR093W |
Caenorhabditis elegans | CELE_Y23H5B.5 | Protein Y23H5B.5 |
Cryptosporidium hominis | Chro.30266 | Flj12787-prov protein |
Cryptosporidium parvum | cgd3_2270 | WD repeat protein |
Dictyostelium discoideum | DDB_G0283581 | U3 small nucleolar ribonucleoprotein |
Drosophila melanogaster | Dmel_CG3071 | CG3071 gene product from transcript CG3071-RA |
Echinococcus granulosus | EgrG_000147200 | U3 small nucleolar RNA associated protein 15 |
Entamoeba histolytica | EHI_170100 | WD domain containing protein |
Echinococcus multilocularis | EmuJ_000147200 | U3 small nucleolar RNA associated protein 15 |
Echinococcus multilocularis | EmuJ_000136900 | U3 small nucleolar RNA associated protein 15 |
Giardia lamblia | GL50803_15026 | Src-associated protein-like protein |
Homo sapiens | ENSG00000164338 | UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) |
Leishmania braziliensis | LbrM.23.0040 | beta propeller protein, putative |
Leishmania donovani | LdBPK_230040.1 | Beta propeller protein 1 |
Leishmania infantum | LinJ.23.0040 | beta propeller protein, putative |
Leishmania major | LmjF.23.0030 | beta propeller protein, putative |
Leishmania mexicana | LmxM.23.0030 | beta propeller protein, putative |
Loa Loa (eye worm) | LOAG_00216 | src-associated protein SAW |
Mus musculus | ENSMUSG00000041747 | UTP15, U3 small nucleolar ribonucleoprotein, homolog (yeast) |
Neospora caninum | NCLIV_016210 | WD domain, G-beta repeat-containing protein, putative |
Oryza sativa | 4342750 | Os07g0224900 |
Saccharomyces cerevisiae | YMR093W | Utp15p |
Schistosoma japonicum | Sjp_0064900 | U3 small nucleolar RNA-associated protein 15 homolog, putative |
Schistosoma mansoni | Smp_045070 | hypothetical protein |
Schmidtea mediterranea | mk4.000054.07 | |
Trypanosoma brucei gambiense | Tbg972.8.1640 | hypothetical protein, conserved |
Trypanosoma brucei | Tb927.8.1980 | Beta propeller protein 1 |
Trypanosoma congolense | TcIL3000_8_2010 | Beta propeller protein 1 |
Trypanosoma cruzi | TcCLB.509499.20 | Beta propeller protein 1 |
Trypanosoma cruzi | TcCLB.508649.10 | Beta propeller protein 1 |
Toxoplasma gondii | TGME49_239590 | WD domain, G-beta repeat-containing protein |
Theileria parva | TP01_1027 | hypothetical protein |
Trichomonas vaginalis | TVAG_462350 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.1980 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.1980 | Trypanosoma brucei | significant loss of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.1980 | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.8.1980 | Trypanosoma brucei | significant loss of fitness in differentiation of procyclic to bloodstream forms | alsford |
YMR093W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_239590 | Toxoplasma gondii | Probably essential | sidik |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.